Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
Journal: Lancet (London, England)
Published: May 29, 2012
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.
Journal: The New England journal of medicine
Published: March 23, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026